Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Dompé Farmaceutici S.p.A., Via San Martino 12-12/a, 20122 Milano, Italy
Okitask 25 mg Film-Coated Tablets is recommended in the symptomatic treatment of acute mild to moderate pain such as rheumatic and muscular pain, headache, toothache, menstrual pain, and for pain and fever associated with common cold and flu symptoms.
Okitask 25 mg Film-Coated Tablets is indicated in adults aged 18 years and over.
| Indication | Age group | Dose | Duration |
|---|---|---|---|
| Symptomatic relief of pain and fever | Adults aged 18 years and over | 1 tablet as a single dose repeated 2 to 3 times a day as needed.* | The minimum effective dose should be used for the shortest time necessary to relieve symptoms (see section 4.4). |
* Leave at least 4 hours between doses.
For short term use only.
Consult a doctor if symptoms persist or worsen, or if the product is required for more than 10 days.
Do not take more than 3 film coated tablets in any 24 hour period.
Ketoprofen Lysine Salt should be used with caution in the elderly.
For elderly patients a dose of 1 tablet a day is recommended.
Ketoprofen should not be used in children and adolescents under the age of 18 years.
Oral use only.
Swallow the tablet whole with a glass of water, if necessary.
The UK National Poisons Information Service considers 10 mg/kg Sprintafen as a toxic dose. In most instances of overdose the symptoms observed are usually limited to lethargy, drowsiness, abdominal pain, nausea, vomiting, which are generally reversible with supportive care. Respiratory depression, coma or convulsions have occurred following large Sprintafen overdoses. GI bleeding, hypotension, hypertension, or acute renal failure may occur but are rare.
There are no specific antidotes for Sprintafen Lysine Salt overdose. Management should occur at a specialised centre, with symptomatic and supportive treatment instituted. It should include maintenance of airway patency, monitoring of cardiac and vital signs, treatment to compensate for dehydration, monitoring of urinary excretion and correction of acidosis. Considered oral administration of active charcoal if the patient presents within 1 hour of ingestion of a potentially toxic amount. Frequent or prolonged convulsions should be treated with intravenous diazepam.
3 years.
Store in the original packaging in order to protect against light and moisture.
Opaque, Al/PA/Al/PVC blister in the following pack sizes: 8, 10, 15, 16, 20 tablets.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
